HONG KONG, March 18, 2019 - Sisram Medical Ltd (`Sisram` or `the Company`) (Hong Kong: 1696), an investment holding company specializing in medical technology for healthcare, today announced its audited consolidated annual results for the 12 months ended December 31, 2018 (`the year`). Results Highlights o Revenue grew to US$154.0 million, an increase of 12% YOY o Gross profit rose to US$82.3 million, an increase of 12% YOY o Profit before tax rose to US$22.8 million, an increase of 44% YOY o Profit for the year rose to US$21.8 million, an increase of 98% YOY o Adjusted net profit reached US$29.5 million, representing 17% YOY growth o Net profit margin: 14%, compared with 8% for 2017 Despite...
|
